29.12.2016 20:01:55
|
Cempra Remains Sharply Lower After Early Sell-Off
(RTTNews) - After falling sharply in early trading, shares of Cempra (CEMP) continue to see substantial weakness in afternoon trading on Thursday. Cempra is currently down by 57 percent after hitting a record intraday low.
The steep drop by Cempra comes after the FDA rejected the pharmaceutical company's new drug applications for oral and intravenous solithromycin for the treatment of community-acquired bacterial pneumonia in adults.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Cempra Holdings LLCmehr Nachrichten
Keine Nachrichten verfügbar. |